Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7069821 | 0.99 | KDM4E (0.52) | POLBKDM4ERECQLPARP1PARP2 | |
| SCHEMBL6833605 | 0.84 | POLB (0.46) | POLBKDM4ERECQLSMN1; SMN2KMT2A | |
| Bromide SCHEMBL3915979 | 0.83 | KDM4E (0.80) | POLBKDM4ERECQLSMN1; SMN2KMT2A | |
| SCHEMBL1105809 | 0.81 | KDM4E (0.77) | POLBKDM4ERECQLSMN1; SMN2KMT2A | |
| Iodide SCHEMBL2057098 | 0.80 | KDM4E (0.75) | POLBKDM4ERECQLSMN1; SMN2KMT2A | |
| SCHEMBL15419914 | 0.80 | KDM4E (0.79) | POLBKDM4ERECQLSMN1; SMN2KMT2A | |
| Bromide SCHEMBL3916333 | 0.75 | KDM4E (0.56) | POLBKDM4ERECQLSMN1; SMN2KMT2A | |
| SCHEMBL16663887 | 0.75 | KDM4E (0.81) | POLBKDM4ERECQLSMN1; SMN2KMT2A | |
| SCHEMBL7069818 | 0.74 | KDM4E (0.54) | POLBKDM4ERECQLSMN1; SMN2KMT2A | |
| Bromide SCHEMBL285416 | 0.72 | POLB (0.72) | POLBKDM4ESMN1; SMN2KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7563907-B2 | Compounds based on polymethines | DYOMICS GMBH (DE) | 2009-07-21 | — | — | US | disclosed |
| US-20040260093-A1 | Compound, especially marker-dye on the basis of polymethines | DYOMICS GMBH (DE) | 2004-12-23 | — | — | US | disclosed |
| US-20030165942-A1 | Compound, especially marker-dye, on the basis of polymethines | DYOMICS GMBH (DE) | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030165942-A1 | Compound, especially marker-dye, on the basis of polymethines | MKI67, CYBA, IK | POLB 1040/4885KDM4E 2432/4885RECQL 1536/4885 |
| US-20040260093-A1 | Compound, especially marker-dye on the basis of polymethines | MKI67, IK, CYBA | POLB 838/4885KDM4E 2399/4885RECQL 1491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.